MTOR and neoplasm: Phosphatidylinositol 3-Kinase (PI3K) and mTOR synergistically promote tumor progression and resistance to chemotherapy; therefore, inhibition of this pathway is an excellent treatment strategy and an efficient tool to avoid or circumvent cancer chemotherapy resistance [166].